USA: COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal.

"Approved COVID vaccines for 2024-25 were made by Moderna and Pfizer-BioNTech, based on the Omicron KP.2 sublineage, and by Novavax, based on the JN.1."

CDC report: https://www.cdc.gov/mmwr/volumes/74/wr/mm7406a1.htm